SEC
RGEN icon

Seven Eight Capital’s Repligen RGEN Stock Holding History

Seven Eight Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,357
Closed -$870K – 700
2021
Q2 		$870K Buy
+4,357
New +$845K 0.12% 290
2020
Q1 		– Sell
-18,069
Closed -$1.67M – 662
2019
Q4 		$1.67M Buy
18,069
+8,300
+85% +$697K 0.09% 339
2019
Q3 		$749K Buy
+9,769
New +$854K 0.04% 465
2019
Q1 		– Sell
-36,921
Closed -$1.95M – 696
2018
Q4 		$1.95M Buy
36,921
+33,000
+842% +$1.94M 0.11% 241
2018
Q3 		$217K Buy
+3,921
New +$202K 0.01% 539

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Seven Eight Capital's RGEN Position: Q3 2021 in Review

Seven Eight Capital sold out of Repligen (RGEN) in Q3 2021, closing a stake of 4,357 shares — an estimated $870K sold.

Seven Eight Capital first reported a position in RGEN in Q3 2018 and held it in 5 quarters. The position peaked at $1.95M in Q4 2018. 479 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

  • Seven Eight Capital reported no remaining Repligen position as of Q3 2021 after selling out during the quarter.
  • Seven Eight Capital sold 4,357 Repligen shares in Q3 2021, an estimated $870K.
  • Seven Eight Capital first reported a position in Repligen in Q3 2018 and held it in 5 quarters.
  • Seven Eight Capital's Repligen position peaked at $1.95M in Q4 2018.
  • 479 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on Seven Eight Capital's 13F filing for Q3 2021, filed 15 Nov 2021.